These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 6406532)

  • 1. Normal plasma gonadotropin response to gonadotropin-releasing hormone after diethylstilbestrol priming in transsexual women.
    Wiesen M; Futterweit W
    J Clin Endocrinol Metab; 1983 Jul; 57(1):197-9. PubMed ID: 6406532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abnormal gonadotropin secretory responses to LRH in transsexual women after diethylstilbestrol priming.
    Seyler LE; Canalis E; Spare S; Reichlin S
    J Clin Endocrinol Metab; 1978 Jul; 47(1):176-83. PubMed ID: 122396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Catecholamines and pituitary-function. V. Effect of low-dose dopamine infusion on basal and gonadotropin-releasing hormone stimulated gonadotropin release in normal cycling women and patients with hyperprolactinemic amenorrhea.
    Nicoletti I; Ambrosi F; Giammartino C; Fedeli L; Mannarelli C; Filipponi P
    Horm Metab Res; 1986 Jul; 18(7):479-84. PubMed ID: 3091473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Evaluation of hypothalamic-pituitary function in amenorrheic women by utilizing the combined clomiphene-GnRH test (author's transl)].
    Kawagoe S; Hiroi M
    Nihon Sanka Fujinka Gakkai Zasshi; 1982 Jul; 34(7):873-9. PubMed ID: 6809864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of an antiprogesterone (RU486) on the hypothalamic-hypophyseal-ovarian-endometrial axis during the luteal phase of the menstrual cycle.
    Garzo VG; Liu J; Ulmann A; Baulieu E; Yen SS
    J Clin Endocrinol Metab; 1988 Mar; 66(3):508-17. PubMed ID: 2832438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gonadotropin, estrogen and progesterone response to long term gonadotropin-releasing hormone infusion at various stages of the menstrual cycle.
    Jewelewicz R; Dyrenfurth I; Ferin M; Bogumil J; Vande Wiele RL
    J Clin Endocrinol Metab; 1977 Oct; 45(4):662-7. PubMed ID: 334788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alterations in hypothalamic and pituitary hormone levels induced by neonatal treatment of female mice with diethylstilbestrol.
    Halling A
    Reprod Toxicol; 1992; 6(4):335-46. PubMed ID: 1521007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subcutaneous administration of gonadotropin-releasing hormone: absorption kinetics and gonadotropin responses.
    Hurley DM; Clarke IJ; Shelton R; Burger HG
    J Clin Endocrinol Metab; 1987 Jul; 65(1):46-52. PubMed ID: 3108305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recovery of hormone secretion after chronic gonadotropin-releasing hormone agonist administration in women with polycystic ovarian disease.
    de Ziegler D; Steingold K; Cedars M; Lu JK; Meldrum DR; Judd HL; Chang RJ
    J Clin Endocrinol Metab; 1989 Jun; 68(6):1111-7. PubMed ID: 2524501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduction in pituitary desensitization and prolongation of gonadotropin release by estrogen during continuous administration of gonadotropin-releasing hormone in women: its antagonism by progesterone.
    Araki S; Chikazawa K; Motoyama M; Ijima K; Abe N; Tamada T
    J Clin Endocrinol Metab; 1985 Mar; 60(3):590-8. PubMed ID: 3919050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of sex steroids on the positive estrogen feedback mechanism in intact women and castrate men.
    Goh HH; Wong PC; Ratnam SS
    J Clin Endocrinol Metab; 1985 Dec; 61(6):1158-64. PubMed ID: 3932451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strength-duration characteristics of estrogen effects on gonadotropin response to gonadotropin-releasing hormone in women. I. Effects of varying duration of estradiol administration.
    Keye WR; Jaffe RB
    J Clin Endocrinol Metab; 1975 Dec; 41(06):1003-8. PubMed ID: 1107343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gonadotropin response to gonadotropin releasing hormone in acute schizophrenia.
    Cantalamessa L; Catania A; Silva A; Orsatti A; Baldini M; Mosca G; Zanussi C; Cazzullo CL
    Prog Neuropsychopharmacol Biol Psychiatry; 1984; 8(3):411-7. PubMed ID: 6435179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation between integrated LH and FSH levels and the response to luteinizing hormone relasing factor (LRF).
    Mortimer RH; Fleischer N; Lev-Gur M; Freeman RG
    J Clin Endocrinol Metab; 1976 Dec; 43(6):1240-9. PubMed ID: 794076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of serum follicle-stimulating hormone bioactivity and isoform distribution by estrogenic steroids in normal women and in gonadal dysgenesis.
    Padmanabhan V; Lang LL; Sonstein J; Kelch RP; Beitins IZ
    J Clin Endocrinol Metab; 1988 Sep; 67(3):465-73. PubMed ID: 3137241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypogonadotropic hypogonadism: hormonal responses to low dose pulsatile administration of gonadotropin-releasing hormone.
    Valk TW; Corley KP; Kelch RP; Marshall JC
    J Clin Endocrinol Metab; 1980 Oct; 51(4):730-8. PubMed ID: 6774991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gonadotropin-releasing hormone (GnRH) analog suppression renders polycystic ovarian disease patients more susceptible to ovulation induction with pulsatile GnRH.
    Filicori M; Campaniello E; Michelacci L; Pareschi A; Ferrari P; Bolelli G; Flamigni C
    J Clin Endocrinol Metab; 1988 Feb; 66(2):327-33. PubMed ID: 3123511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gonadotropin responses to gonadotropin-releasing hormone and prolactin responses to thyrotropin-releasing hormone and metoclopramide in women with amenorrhea and insulin-treated diabetes mellitus.
    Djursing H; Hagen C; Nyholm HC; Carstensen L; Andersen AN
    J Clin Endocrinol Metab; 1983 May; 56(5):1016-21. PubMed ID: 6403566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maturation of the hypothalamo-pituitary-ovarian axis in adolescent girls.
    Lemarchand-Béraud T; Zufferey MM; Reymond M; Rey I
    J Clin Endocrinol Metab; 1982 Feb; 54(2):241-6. PubMed ID: 6798063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Melatonin enhances the luteinizing hormone and follicle-stimulating hormone responses to gonadotropin-releasing hormone in the follicular, but not in the luteal, menstrual phase.
    Cagnacci A; Paoletti AM; Soldani R; Orrù M; Maschio E; Melis GB
    J Clin Endocrinol Metab; 1995 Apr; 80(4):1095-9. PubMed ID: 7714075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.